This supports the hypothesis that hyperglycemia-induced impairment in insulin signaling exacerbates neuroinflammation and tau pathology and is in line with previous studies showing a link between metabolic dysfunction and cognitive impairment in diabetes. The gene discussed is MAPT; the disease is Cognitive impairment.